Skip to main content
. 2015 Dec 8;71(2):161–170. doi: 10.1136/thoraxjnl-2015-207140

Table 1.

Demographic, risk and medical characteristics of n=4055 individuals randomised to the UK Lung Cancer Screening (UKLS) intervention (CT screen) and control (non-screen) trial arms

  Total n=4055
Screen arm (n=2028) Control arm (n=2027)
Male:female ratio 1529:499 (3.06:1) 1507:520 (2.90:1)
North:south ratio 1023:1005 (1.02:1) 1023:1004 (1.02:1)
Mean (SD) age, years 67.1 (4.1) 66.9 (4.1)
Median age, years 67 67
Median IMD rank* 17 374 17 704
Mean (SD) LLPv2 score 8.87 (5.12) 8.83 (4.71)
Median LLPv2 score 7.11 7.35
Never smokers 2 (0.1) 0 (0%)
Current smokers 777 (38.3%) 791 (39.0%)
Ex-smokers 1249 (61.6%) 1236 (61.0%)
Smoking duration 10–19 years† 117 (5.8%) 116 (5.7%)
Smoking duration 20+ years† 1895 (93.4%) 1907 (94.1%)
Smoking duration unknown† 14 (0.7%) 4 (0.2%)
% Asbestos exposed 763 (37.6%) 763 (37.6%)
% with history of respiratory disease‡ 1056 (52.1%) 1023 (50.5%)
% with history of blood cancer§ 26 (1.28%) 31 (1.53%)
% with history of solid tumour¶ 378 (18.6%) 396 (19.5%)
Total % with family history of lung cancer 498 (24.6%) 554 (27.3%)
% with family history of lung cancer <60 years 215 (10.6%) 215 (10.6%)
% with family history of lung cancer >60 years 283 (14.0%) 339 (16.7%)
Family history of other cancer (not lung)** 1026 (50.6%) 1019 (50.3%)

†All smoking duration figures refer to current and ex-smokers combined.

‡Asthma, bronchitis, TB, pneumonia, COPD or emphysema.

§Leukaemia or lymphoma, including Hodgkin's.

¶Cancers of brain, head and neck, oesophagus, breast, colon or ‘other’.

**Cancers of brain, head and neck, oesophagus, breast, colon or ‘other’.

LLP, Liverpool Lung Project.